Shalby Ltd. · NSE:SHALBY
Shalby — Q1 FY2024 Earnings Presentation
37 slides from Shalby's earnings presentation, Jul 20, 2023
Slide 1: Exchange filing cover letter for Investor Presentation
July 20, 2023 Shalby/SE/2023‐24/43 The Listing Department Corporate Service Department National Stock Exchange of India Ltd BSE Limited Mumbai 400 051. Mumbai 400 001. Scrip Code : SHALBY Scrip Code: 540797 Through : https://neaps.nseindia.com/NEWLISTINGCORP/ Through : http://listing.bseindia.com Su
Slide 2: Investor Presentation Q1 FY2024
Investor Presentation Q1 FY2024
Slide 3: Agenda
AGENDA 01 SHALBY GROUP QUARTERLY AND ANNUAL PERFORMANCE 02 HOSPITAL BUSINESS QUARTERLY AND ANNUAL PERFORMANCE 03 HOMECARE BUSINESS QUARTERLY AND ANNUAL PERFORMANCE 04 FRANCHISE BUSINESS QUARTERLY AND ANNUAL PERFORMANCE 05 SHALBY ACADEMY QUARTERLY AND ANNUAL PERFORMANCE 06 IMPLANT BUSINESS QUARTERLY
Slide 4: Consolidated Snapshot Q1 FY24
Consolidated Snapshot Q1 FY24 Consolidated Revenue at Rs 2,400 mn in Q1 FY24 grew by 15% QoQ and 17% YoY Financial Highlights Hospital business Revenue at Rs.2,164 mn in Q1 FY24 grew by 18 % QoQ and 20% YoY Implant business Revenue at Rs.164 mn in Q1 FY24 de-grew by (21)% QoQ and (38)% YoY Consolida
Slide 5: Consolidated Performance Highlights - Q1 FY24
Consolidated Performance Highlights - Q1 FY24 Revenue (INR MN) EBITDA1 (INR MN) 2,400 477 440 2,057 2,082 348 Margin % 21.4 % 16.7 % 19.9 % Q1 FY23 Q4 FY23 Q1 FY24 Q1 FY23 Q4 FY23 Q1 FY24 16.7% 8.2% PBT (INR MN) ROCE (%) 330 16.6% 306 13.2% 11.4% 192 14.9 % 9.2 % 13.7 % Q1 FY23 Q4 FY23 Q1 FY24 FY 22
Slide 6: Consolidated P/L & B/S (Q1 FY24)
Consolidated P/L & B/S (Q1 FY24) Profit & Loss (NR Mn) Balance Sheet (INR Mn) Q1 Q4 Q-o-Q Q1 Y-o-Y Gross 1,087 Particulars (Rs. Millions) Borrowings FY24 FY23 Growth FY23 Growth Cash & Cash 1,892 Revenue 2,400 2,082 15.3% 2,057 16.7% Equivalents EBITDA 477 348 36.8% 440 8.2% Net Cash/(Debt) 806 EBIT
Slide 7: Diversification in Revenue Mix
High Growth Business Verticals Healthcare Conglomerate Building An Integrated Orthopedic Solutions Ecosystem Multi-Specialty Franchise Implant 9 Hospitals across western and 6 Hospital network USA based Knee & Hip central India Manufacturing facility Synergistic Sustainable Business Model • Headroom
Slide 8: A Legend and Visionary Doctorpreneur behind Shalby
A Legend and Visionary Doctorpreneur behind Shalby Dr Vikram I. Shah, the Founder of Shalby Ltd, is a world-renowned Joint Replacement Surgeon who innovated “Zero Technique” that revolutionized Joint Replacement Surgery. A visionary entrepreneur, he transformed Shalby from a 6 bedded hospital in 199
Slide 9: Standalone Performance (Hospital Business)
Standalone Performance (Hospital Business) 8
Slide 10: Hospital Business Highlights Q1 FY24
Hospital Business Highlights Q1 FY24 Global leader in Arthroplasty with 1,50,000+ Joint replacement surgeries and other core surgeries grew by higher double digits Surgery Count and QoQ Growth Operational Performance Q1 Q4 QoQ Q1 YoY Particulars FY24 FY23 Growth FY23 Growth Arthroplasty Nephro & Uro
Slide 11: Standalone Business Highlights (Q1 FY24)
Standalone Business Highlights (Q1 FY24) Financial Performance Revenue (INR Mn) EBITDA (INR Mn) 2,164 497 428 365 1,810 1,836 • Revenue at INR 2,164 mn up by 18% QoQ and 20% YoY 23.6 % 19.9 % 23.0 % • EBITDA at INR 497 mn up by 36% QoQ and 16% YoY Q1 FY23 Q4 FY23 Q1 FY24 Q1 FY23 Q4 FY23 Q1 FY24 19.5
Slide 12: Standalone P&L and B/S (Q1 FY24)
Standalone P&L and B/S (Q1 FY24) Profit & Loss (Rs. Mn) Total Revenue to EBITDA Consistent Q1 Q4 QoQ Q1 YoY Double Digit 19.9% EBITDA 23.0% 23.6% Particulars (Rs Mn) FY24 FY23 Growth FY23 Growth Operating Margin Materials and Consumables 26.0% Total Revenue 2,164 1,836 17.9% 1,810 19.5% 26.4% 26.4%
Slide 13: Hospital Business Highlights: Specialty Revenue Mix
Hospital Business Highlights Specialty Revenue Mix Q1 FY2024 Q4 FY2023 Q1 FY2023 Others, 11% Others, 12% Nephrology, Others, 13% Nephrology, 5% Nephrology, Arthroplasty 4% Arthroplasty 5% , 41% Arthroplasty Neurology, , 45% 4% , 44% Neurology, 4% Neurology, 5% Orthopaedic , 8% Orthopaedic , 7% Ortho
Slide 14: Hospital Business Highlights: Payor Mix
Hospital Business Highlights Payor Mix Q1 FY2024 Q4 FY2023 Q1 FY2023 Corporate, Corporate, Corporate, 1% 1% 3% Self Pay, Self Pay, 33% 36% Self Pay, Governme Governme Governme 35% nt, 25% nt, 23% nt, 22% Insurance, Insurance, Insurance, 41% 40% 40% 13
Slide 15: Standalone Business Highlights Annual Growth
Standalone Business Highlights Annual Growth Shalby Continued to deliver high double-digit growth over the last 2 decades Revenue (INR Mn) EBITDA (INR Mn) 7,274 1,615 6,598 1,426 778 3,284 439 1,685 194 22 FY 2007 FY 2012 FY 2017 FY 2022 FY 2023 FY 2007 FY 2012 FY 2017 FY 2022 FY 2023 14
Slide 16: Homecare Business Highlights Q1 FY 2024
Homecare Business Highlights Q1 FY 2024 Q1 FY2024 Highlights Patients Served (Nos) 31% YoY 7,695 Patients Served 7,695 in Q1 FY24 v/s 5,868 patients in Q1 FY23, 7,139 & 8% QoQ grew by 31% YoY 5,868 Revenue booked Rs.36.56 mn in Q1 FY24 v/s Rs.21.50 mn in Q1 FY23, grew by 70% YoY Q1 FY23 Q4 FY23 Q1 F
Slide 17: Clinical Update And Research Across Units during Q1 FY24
Clinical Update And Research Across Units during Q1 FY24 ▪ 15 Transplants (10 Kidney and 5 Liver) in Q1 FY24 with this we have performed 250+ Transplants so far at our SG and Indore units ▪ Severely burn injury patient with damage to eyes treated successfully with embryotic membrane grafting in both
Slide 18: Key Focus Areas For Future In Hospital business
Key Focus Areas For Future In Hospital business Global Leader in Joint Replacement with diversification in other specialties • Continue to maintain global leadership in joint replacements • Ongoing diversification with Cardiac Science, Oncology, Neuro-science, Critical Care, General Medicine and Tra
Slide 19: Franchise Performance (Hospital)
FRANCHISE Performance (Hospital) 18
Slide 20: Leveraging Expertise Through Franchise Asset Light Model
Leveraging Expertise Through Franchise Asset Light Model Franchise model will leverage Shalby expertise and enable to penetrate faster across pan-India Business models SOCE Performance in Q1 FY24 Franchise Owned – Shalby Operated (FOSO) • Total Surgeries performed at SOCE units (operated and managed
Slide 21: Shalby Academy
CO) SHALBY ACADEMY
Slide 22: Shalby Academy
Shalby Academy Q1 FY24 highlights Students Enrolled (In Nos) 1. More than 290+ students registered in Q1 FY24 in various disciplines like Physiotherapy, Nursing, Lab Technician Nutrition & dietetics, 2,062 17x growth Clinical, Paramedics, Hospital Management, and Pharmacy as part of their academic o
Slide 23: Implant Business Performance
IMPLANT BUSINESS Performance 22
Slide 24: Diversified into Knee and Hip Implant Manufacturing In California, USA
Diversified into Knee and Hip Implant Manufacturing In California, USA Backward integration in Orthopedics with Inhouse capacity to consume in India 80,000+ Vertically integrated In- Components High Quality US FDA house manufacturing Manufacturing Approved Implants Facility capacity Surgeon’s Traini
Slide 25: Implant Business Performance Q1 FY24
Implant Business Performance Q1 FY24 Total Constructs EBITDA Revenue Sold Rs. 164 mn Rs. (3.5) mn 1,410+ Geographical Sales Mix USA Customer Sales Mix Product Sales Mix India, Retail, Hip, 30% 52% 42% Q1 FY24 Q1 FY24 Q1 FY24 Wholes ale, 48% Knee, USA, 70% 58% 24
Slide 26: Implant Business Roadmap
Implant Business Roadmap Shalby Advanced Technologies plans to become a Global player in a phased manner Existing Phase 1 Phase 2 Phase 3 Market Latin America Middle East Countries East Africa North America • Argentina • UAE • Kenya • Columbia • Saudi Arabia • Ethiopia Japan South-East and North • O
Slide 27: 29 Years of ELITE Legacy
29 Years of ELITE Legacy Integrity Highest standards of transparency accountability, and corporate governance Learning Team Work Laser sharp focus on A patient-centric focused upgrading the skills of team with a great blend of our team and building experience, diversity, fresh people capability thin
Slide 28: Our Journey & Expansion Plan
Our Journey & Expansion Plan • Jaipur Shalby, Jaipur (237 beds) • Naroda Shalby, Ahmedabad (267 beds) Vijay Shalby, Ahmedabad • Vapi Shalby, Vapi (146 beds) • • Surat Shalby, Surat (243 beds) • Lucknow SOCE, 40 beds 27 beds • Krishna Shalby, Ahmedabad (220 • Zynova1 Shalby, Mumbai (150 beds) • Gwali
Slide 29: Hospitals Portfolio
Hospitals Portfolio Multispecialty Units (Owned and Operate) Vapi Shalby Indore Shalby Jaipur Shalby Krishna Shalby Mohali Shalby Naroda Shalby SG Shalby Jabalpur Shalby Surat Shalby 28
Slide 30: Franchise Hospital Portfolio
Franchise Hospital Portfolio Shalby Orthopedics Centre of Excellence Multispecialty Vijay Shalby Lucknow Shalby Zynova Shalby (Mumbai) (Shalby Operated) (Shalby Operated) Udaipur Shalby Gwalior Shalby Ranchi Shalby (Shalby Managed) (Shalby Managed) SOCE- Shalby Orthopedics Centre of Excellence 29
Slide 31: Biggest Healthcare Corporate Group in Western and Central India
Biggest Healthcare Corporate Group in Western and Central India 2000+ Bed Capacity National Presence 12 Cities and 7 States 59 OPDs across 16 States PUNJAB ▪ Mohali – 145 beds Uttar Pradesh ▪ Lucknow – 40 beds Upcoming Units RAJASTHAN MAHARASHTRA ▪ Jaipur – 237 beds ▪ Mumbai (Santacruz) – 175 beds ▪
Slide 32: Sustainability Initiatives
Sustainability Initiatives ESG Mindset “We at Shalby are embracing sustainability to drive new values to our business” Community Connect 230+ Healthcare Camps Trainings Healthcare Awareness Programs Workplace Wellness 11000+ Life impacted 10,640+ and 5,790+ Man Hours Clinical and Non-Clinical traini
Slide 33: Experienced Board Of Directors
Experienced Board Of Directors Dr. Vikram Shah Chairman and Managing Dr. Ashok Bhatia Mr. Tej Malhotra Ms. Sujana Shah Director Independent Director Independent Director Independent Director Dr. Vikram Shah, serving as Director of the Department Mr. Malhotra comes with over four decades of Dr. Ashok
Slide 34: Shalby Awards and Accolades
Shalby Awards and Accolades Mr. Shanay shah, shalby's president, awarded by FICCI Medical Value Travel Specialist Award 2023 business world healthcare (Orthopedics & Joint Replacement) to Krishna Shalby with 40U40 award Hospital Medgate Today Healthcare Award 2023 for Shalby Orthopedics Centre of Ex
Slide 35: Shalby In News
Shalby In News SHALBYCON 2023, National Critical Care Conference at Ahmedabad 34
Slide 36: Shalby In News
Shalby In News Launch of Cancer Awareness Bus on World Cancer Day Inauguration of ‘Matritva Care Unit’ at Shalby Hospital Jaipur 200 Cancer Winners Celebrated their Victory Over Cancer at Naroda Shalby 35
Slide 37: Disclaimer and Contact Details
DISCLAIMER and CONTACT DETAILS No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as